Cargando…
NDRG4 stratifies the prognostic value of body mass index in colorectal cancer
NDRG4 is a novel candidate tumor suppressor and can inhibit PI3K/AKT signal which is related with energy balance and related carcinogenesis. In the present study, we investigated whether NDRG4 status could modify the association of obesity with clinical outcome of colorectal cancer. For this purpose...
Autores principales: | Zheng, Jianyong, Li, Yunming, Zhu, Shaojun, Li, Jipeng, Zhao, Qingchuan, Ji, Gang, Wang, Weizhong, Chu, Dake |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4811462/ https://www.ncbi.nlm.nih.gov/pubmed/26515606 |
Ejemplares similares
-
NDRG4, a novel candidate tumor suppressor, is a predictor of overall survival of colorectal cancer patients
por: Chu, Dake, et al.
Publicado: (2015) -
Increased MicroRNA-630 Expression in Gastric Cancer Is Associated with Poor Overall Survival
por: Chu, Dake, et al.
Publicado: (2014) -
CD147 Expression in Human Gastric Cancer Is Associated with Tumor Recurrence and Prognosis
por: Chu, Dake, et al.
Publicado: (2014) -
The prognostic impact of BMI on colorectal cancer is stratified by tumor location
por: Zhang, Zixi, et al.
Publicado: (2022) -
Characterization of the prognostic values of the
NDRG family in gastric cancer
por: Yu, Chaoran, et al.
Publicado: (2019)